InSilico Medicine Cayman TopCo Stock price
Compare with Peer Group
Is InSilico Medicine Cayman TopCo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,114 stocks worldwide.
Key metrics
InSilico Medicine Cayman TopCo Stock Analysis
Analyst Opinions
14 Analysts have issued a InSilico Medicine Cayman TopCo forecast:
Analyst Opinions
14 Analysts have issued a InSilico Medicine Cayman TopCo forecast:
Don't miss a Thing! We will send you all news about InSilico Medicine Cayman TopCo directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. The company employs 317 full-time employees The company went IPO on 2025-12-30. The firm is engaged in the research and development of drug discovery engines. In addition, the Company is engaged in the copabdrug discovery and development of disease target identification, generation of novel molecules data, and predicting clinical trial outcomes.
| Head office | Hong Kong |
| Website | www.insilico.com |


